Ultrasound Assessment of Pediatric Fracture Healing With the PLUS Score

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-14
SponsorUniversity Hospital Hradec Kralove

About this trial

This observational study investigates whether ultrasound can safely and accurately monitor the healing of bone fractures in children, comparing it to standard X-rays. Currently, children with fractures often require multiple X-rays during their recovery, which exposes them to small amounts of ionizing radiation. Ultrasound, on the other hand, is completely radiation-free.

The study aims to evaluate a specific ultrasound scoring system called the PLUS (Pediatric Long-bone Ultrasound Score) score. The study will include pediatric patients who are being treated conservatively (e.g., with a cast) for a long bone fracture, fractures of the sternum, patella and clavicle. During their regularly scheduled follow-up visits, participants will receive a brief ultrasound scan of the fracture site in addition to their standard clinical and X-ray examinations. The medical decisions regarding the patient's treatment will continue to be based entirely on standard care.

The main goal is to determine if the ultrasound PLUS score strongly correlates with the X-ray findings. If proven accurate, this scoring system could help reduce the need for routine X-rays in the future, thereby minimizing radiation exposure and potentially streamlining outpatient workflow.

Eligibility criteria

Qualifiers

Age 0 to 14 years.

Acute fracture of a clavicle, sternum, patella, or long bone.

Conservative treatment planned or ongoing, including closed reduction and immobilization/casting.

Scheduled for routine outpatient follow-up with clinical and radiographic assessment.

Disqualifiers

Fractures treated surgically, including internal or external fixation.

Pathological fractures.

Metabolic bone disease or known bone fragility disorder.

Severe polytrauma or unstable clinical condition.

Trial design

Treatments tested in this trial

  • Point-of-care ultrasound

Treatment groups

1,200 Participants
are divided into 1 treatment group

Sponsors and collaborators